Pierre Vogel, Gerardo Turcatti, Marc Chambon, Somi Reddy Majjigapu, Olivier Michielin
Indoleamine 2,3-dioxygenase 1 (IDO1) is a key regulator of immune responses and therefore an important therapeutic target for the treatment of diseases that involve pathological immune escape, such as cancer. Here, we describe a robust and sensitive high-t ...
Elsevier France-Editions Scientifiques Medicales Elsevier2014